Paradoxical Acute Hypercalcemic Effect of Salmon Calcitonin in Patients Having Paget's Disease of Bone after Treatment with Dichloromethylene Diphosphonate

1984 ◽  
Vol 16 (05) ◽  
pp. 258-261
Author(s):  
P. Delmas ◽  
M. Chapuy ◽  
P. Meunier
Keyword(s):  
Salmon Calcitonin ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Dichloromethylene Diphosphonate

Dichloromethylene Diphosphonate (Cl2MDP) as an Inhibitor of Bone Resorption in Paget's Disease of Bone

1980 ◽  
Vol 58 (2) ◽  
pp. 24P-24P
Author(s):  
D. L. Douglas ◽  
T. Duckworth ◽  
J. A. Kanis ◽  
C. J. Preston ◽  
J. S. Woodhead ◽  
...  
Keyword(s):  
Bone Resorption ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Dichloromethylene Diphosphonate

scholarly journals Treatment of Paget's Disease of Bone with Synthetic Salmon Calcitonin

BMJ ◽  
1974 ◽  
Vol 3 (5933) ◽  
pp. 727-731 ◽  
Author(s):  
J. A. Kanis ◽  
D. B. Horn ◽  
R. D. M. Scott ◽  
J. A. Strong
Keyword(s):  
Salmon Calcitonin ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Synthetic Salmon Calcitonin

Long Term Effects of Dichloromethylene Diphosphonate in Paget's Disease of Bone

1982 ◽  
Vol 54 (4) ◽  
pp. 837-844 ◽  
Author(s):  
PIERRE D. DELMAS ◽  
M. C. CHAPUY ◽  
E. VIGNON ◽  
S. CHARHON ◽  
D. BRIANCON ◽  
...  
Keyword(s):  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Long Term Effects ◽  
Dichloromethylene Diphosphonate

The Therapeutic Uses of Calcitonin

1978 ◽  
Vol 23 (2) ◽  
pp. 161-165 ◽  
Author(s):  
T. J. Martin
Keyword(s):  
Bone Resorption ◽  
Therapeutic Effect ◽  
Salmon Calcitonin ◽  
Bone Pain ◽  
Paget’S Disease ◽  
Paget's Disease ◽  
Paget’S Disease Of Bone ◽  
Paget's Disease Of Bone ◽  
Therapeutic Uses ◽  
Histological Improvement

Calcitonin is a potent hormonal inhibitor of bone resorption. Its major therapeutic effect is in the treatment of Paget's Disease of bone, in which it has been shown to reduce bone pain, lead to radiological and histological improvement in bone, and to restore abnormal biochemistry towards normal. Some patients are resistant to treatment, and in others resistance may develop during treatment. Although antibodies to pig or to salmon calcitonin develop in almost 50 per cent of treated patients it is only very rarely that resistance may be ascribed to antibodies. There are a number of other clinical states of increased resorption in which the value of calcitonin therapy has yet to be established.

Sign in / Sign up

Export Citation Format

Share Document